PGHH Approves Unaudited Financial Results for Quarter Ended September 30, 2025
PGHH's Board approved unaudited financial results for the quarter ended September 30, 2025. Total income reached ₹1,160.07 lakh, with a profit before tax of ₹281.78 lakh and EPS of ₹64.65.
The announcement provides information about the company's financial performance, which is relevant to investors and can influence stock prices.
The announcement is factual, reporting the approval of quarterly results without expressing positive or negative outlooks.
* PGHH's Board of Directors approved the unaudited financial results for the quarter ended September 30, 2025, in a meeting held on November 6, 2025, which commenced at 12:50 P.M. and concluded at 01:18 P.M. * The total income for the quarter stood at ₹1,160.07 lakh. * The profit before tax was ₹281.78 lakh. * The profit for the period was ₹209.86 lakh. * Basic and diluted earnings per share were ₹64.65. * The previous Financial Year of the Company viz., 2024-25 was for a period of nine months commencing on July 1, 2024, and ended on March 31, 2025.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.